IHS Chemical Week

EnviroTech :: Regulatory

Merck & Co. to Settle Vioxx Claims

11:03 AM MST | November 20, 2007 | Chemical Week Editorial Staff

Merck & Co. agreed earlier this month to pay a total of $4.85 billion to 47,000 groups of plaintiffs to settle a class-action lawsuit related to Vioxx, Merck’s former blockbuster painkiller drug that was withdrawn from the market in 2004. Vioxx was withdrawn because of side-effects including heart attacks and strokes that resulted in a number of patient deaths. Merck says it will pay the settlement into a fund and that plaintiffs may petition to receive a portion of the amount. Plaintiff groups include patients who had been prescribed Vioxx, and the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa